| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | SYNVISC-ONE |
| Generic Name | Acid, hyaluronic, intraarticular |
| Applicant | Sanofi Genzyme Corp. 450 Water St. Cambridge, MA 02141 |
| PMA Number | P940015 |
| Supplement Number | S012 |
| Date Received | 06/19/2007 |
| Decision Date | 02/26/2009 |
| Product Code |
MOZ |
| Docket Number | 09M-0128 |
| Notice Date | 03/10/2009 |
| Advisory Committee |
Orthopedic |
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement APPROVAL FOR THE SYNVISC-ONE. THE DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS OF THE KNEE IN PATIENTS WHO HAVE FILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND SIMPLE ANALGESICS, E.G., ACETAMINOPHEN. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling
|
|
|